Published in J Cell Physiol on July 01, 2009
New insights into the mechanisms of embryonic stem cell self-renewal under hypoxia: a multifactorial analysis approach. PLoS One (2012) 0.83
Direct head-to-head comparison of cationic liposome-mediated gene delivery to mesenchymal stem/stromal cells of different human sources: a comprehensive study. Hum Gene Ther Methods (2013) 0.80
Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 12.54
A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol (1980) 6.96
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A (1994) 4.57
Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol (1984) 4.55
A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med (1998) 3.20
Reversible expression of CD34 by murine hematopoietic stem cells. Blood (1999) 2.86
Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest (1988) 2.53
A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. Blood (1995) 1.96
Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol (1998) 1.84
Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood (1994) 1.64
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood (1991) 1.64
Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol (1999) 1.47
A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods (1999) 1.46
Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood (1999) 1.29
Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents (2001) 1.27
Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells (1998) 1.26
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol (1994) 1.26
CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity (2005) 1.22
Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells. J Biol Chem (1998) 1.22
Analysis of primitive CD34- and CD34+ hematopoietic cells from adults: gain and loss of CD34 antigen by undifferentiated cells are closely linked to proliferative status in culture. Stem Cells (2004) 1.15
The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci U S A (1995) 1.14
Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood (1995) 1.12
A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol (2005) 1.08
Reversible cell surface expression of CD38 on CD34-positive human hematopoietic repopulating cells. Exp Hematol (2007) 1.08
Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells. Blood (2001) 1.03
Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol (2003) 1.00
Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood (2002) 1.00
Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med (1993) 0.99
Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood (1996) 0.97
Statistical determination of threshold for cellular division in the CFSE-labeling assay. J Immunol Methods (2006) 0.96
Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci (1995) 0.90
Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood (2002) 0.89
A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Exp Hematol (2006) 0.89
Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Hematol (1994) 0.89
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells. Stem Cells (2008) 0.88
A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp Hematol (2005) 0.88
Developmental changes in the function of hematopoietic stem cells. Exp Hematol (1995) 0.86
Potential of CD34 in the regulation of symmetrical and asymmetrical divisions by hematopoietic progenitor cells. Stem Cells (2006) 0.84
Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood (1994) 0.83
Expression of interleukin-1 beta gene in candidate human hematopoietic stem cells. Blood (1994) 0.83
Angiopoietin-1 supports induction of hematopoietic activity in human CD34- bone marrow cells. Exp Hematol (2007) 0.83
Evaluation of serum-free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model. J Hematother Stem Cell Res (2000) 0.76
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 4.37
Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology (2006) 2.26
Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation (2011) 1.99
Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol (2010) 1.60
High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol (2009) 1.56
Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther (2006) 1.51
Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line. Cancer Biol Ther (2009) 1.47
Ulcerative colitis in northern Portugal and Galicia in Spain. Inflamm Bowel Dis (2010) 1.42
Formation of human hepatocytes by human hematopoietic stem cells in sheep. Blood (2004) 1.26
Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology (2007) 1.24
Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng Part C Methods (2011) 1.24
Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood (2005) 1.23
Three-dimensional cell culture microarray for high-throughput studies of stem cell fate. Biotechnol Bioeng (2010) 1.22
Stem cell cultivation in bioreactors. Biotechnol Adv (2011) 1.21
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev (2010) 1.18
Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart. Circulation (2004) 1.14
Expansion of mouse embryonic stem cells on microcarriers. Biotechnol Bioeng (2007) 1.13
Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol (2010) 1.10
A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol (2005) 1.08
On-chip, cell-based microarray immunofluorescence assay for high-throughput analysis of target proteins. Anal Chem (2008) 1.06
Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol (2002) 1.06
The correlation between the adsorption of adhesive proteins and cell behaviour on hydroxyl-methyl mixed self-assembled monolayers. Biomaterials (2008) 1.04
Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol (2003) 1.03
Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol (2003) 1.00
Bone marrow stem cells and liver regeneration. Exp Hematol (2010) 0.99
Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-DE-based quantitative proteomics. PLoS One (2012) 0.99
Purification of interstitial cells of Cajal by fluorescence-activated cell sorting. Am J Physiol Cell Physiol (2003) 0.98
Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br J Haematol (2004) 0.97
Ethanol biosensors based on alcohol oxidase. Biosens Bioelectron (2004) 0.97
Ion jelly: a tailor-made conducting material for smart electrochemical devices. Chem Commun (Camb) (2008) 0.95
The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hematopoietic grafts' potential. Exp Hematol (2007) 0.94
Differentiative potential of human metanephric mesenchymal cells. Exp Hematol (2002) 0.94
Purification and identification of cutinases from Colletotrichum kahawae and Colletotrichum gloeosporioides. Appl Microbiol Biotechnol (2006) 0.92
Generation of tissue-specific cells from MSC does not require fusion or donor-to-host mitochondrial/membrane transfer. Stem Cell Res (2008) 0.92
Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence. Innate Immun (2012) 0.92
Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer. Mol Ther (2005) 0.91
Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes. Blood (2005) 0.91
The sheep model of in utero gene therapy. Fetal Diagn Ther (2003) 0.90
Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II). Inflamm Bowel Dis (2013) 0.89
Bioactivity of immobilized EGF on self-assembled monolayers: optimization of the immobilization process. J Biomed Mater Res A (2010) 0.89
Impact of hypoxia and long-term cultivation on the genomic stability and mitochondrial performance of ex vivo expanded human stem/stromal cells. Stem Cell Res (2012) 0.89
Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins. PLoS One (2012) 0.89
A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Exp Hematol (2006) 0.89
Different stages of pluripotency determine distinct patterns of proliferation, metabolism, and lineage commitment of embryonic stem cells under hypoxia. Stem Cell Res (2010) 0.89
Ex vivo expansion of human mesenchymal stem cells on microcarriers. Methods Mol Biol (2011) 0.89
Integration of the production and the purification processes of cutinase secreted by a recombinant Saccharomyces cerevisiae SU50 strain. J Biotechnol (2004) 0.89
Mycobacterium sp., Rhodococcus erythropolis, and Pseudomonas putida behavior in the presence of organic solvents. Microsc Res Tech (2004) 0.88
Distinct contribution of human cord blood-derived endothelial colony forming cells to liver and gut in a fetal sheep model. Hepatology (2012) 0.88
Hypoxia enhances proliferation of mouse embryonic stem cell-derived neural stem cells. Biotechnol Bioeng (2010) 0.88
Bioreactor design for clinical-grade expansion of stem cells. Biotechnol J (2013) 0.88
The fetal sheep: a unique model system for assessing the full differentiative potential of human stem cells. Yonsei Med J (2004) 0.88
Concise review: Genomic instability in human stem cells: current status and future challenges. Stem Cells (2014) 0.86
Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells. Mol Biosyst (2010) 0.86
Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells. Exp Hematol (2008) 0.86
Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells. J Tissue Eng Regen Med (2010) 0.86
Development of quantitative PCR methods to analyse neural progenitor cell culture state. Biotechnol Appl Biochem (2006) 0.86
A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells. Biotechnol Bioeng (2014) 0.85
Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Mol Ther (2005) 0.85
Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC. Exp Hematol (2011) 0.85
Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media. Biotechnol J (2013) 0.85
Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion. Exp Hematol (2008) 0.85
Gene delivery to human bone marrow mesenchymal stem cells by microporation. J Biotechnol (2010) 0.84
Reprocessing practice in digestive endoscopy units of district hospitals: results of a Portuguese National Survey. Eur J Gastroenterol Hepatol (2011) 0.84
The effect of hypoxia and stem cell source on haemoglobin switching. Br J Haematol (2005) 0.84
Plasticity of human stem cells in the fetal sheep model of human stem cell transplantation. Int J Hematol (2004) 0.84
Kinetic and metabolic analysis of mouse embryonic stem cell expansion under serum-free conditions. Biotechnol Lett (2009) 0.84
Crohn's disease in a southern European country: Montreal classification and clinical activity. Inflamm Bowel Dis (2009) 0.84